What Might the Future Hold for Patients with PsA

Conference|Maui Derm NP+PA Summer

Arthur Kavanaugh, MD, a professor of medicine and director of the Center for Innovative Therapy (CIT) at UC San Diego in California, gives his thoughts on the future of psoriatic arthritis.

Related Videos
Related Content

Highlights from AAD 2023

March 23rd 2023

The Cutaneous Connection: Using the Color Wheel to Discuss Nutrition

March 26th 2022

AAD 2023 Pearls from Zoe Diana Draelos, MD

March 22nd 2023

The Cutaneous Connection: Episode 30- Impact of the JAK Inhibitor Approval Delays

September 2nd 2021

Phase 3 Data for Bimekizumab Shows Well Maintained Response

March 21st 2023

25.1% of Patients Cited “Less Noticeable” Vitiligo in Recent Study

March 21st 2023

Highlights from AAD 2023

March 23rd 2023

The Cutaneous Connection: Using the Color Wheel to Discuss Nutrition

March 26th 2022

AAD 2023 Pearls from Zoe Diana Draelos, MD

March 22nd 2023

The Cutaneous Connection: Episode 30- Impact of the JAK Inhibitor Approval Delays

September 2nd 2021

Phase 3 Data for Bimekizumab Shows Well Maintained Response

March 21st 2023

25.1% of Patients Cited “Less Noticeable” Vitiligo in Recent Study

March 21st 2023

Highlights from AAD 2023

March 23rd 2023

The Cutaneous Connection: Using the Color Wheel to Discuss Nutrition

March 26th 2022

AAD 2023 Pearls from Zoe Diana Draelos, MD

March 22nd 2023

The Cutaneous Connection: Episode 30- Impact of the JAK Inhibitor Approval Delays

September 2nd 2021

Phase 3 Data for Bimekizumab Shows Well Maintained Response

March 21st 2023

25.1% of Patients Cited “Less Noticeable” Vitiligo in Recent Study

March 21st 2023
© 2023 MJH Life Sciences

All rights reserved.